- Indication
- Diabetes letter self funder (Herts)
- RAG rating
- Amber initiation
- Document type
- Prescribing guideline
- Place
- East and North Hertfordshire
South and West Hertfordshire - Output type
- Pharmacy / Prescribing
- Document
- Download
Dexcom ONE
Report Summary to General Practitioner from Diabetes Specialist about your Patient
(Continuation of Dexcom ONE Continuous Glucose Monitoring System Technology)
NHS Number: .…………………………………………………………………..
Name: ……………………………………………………………………
D.O.B.: ……………………………………………………………………
Dear Doctor
Your patient was seen on …./…../………. by the diabetes specialist team for assessment of suitability for NHS funding of Dexcom ONE Continuous Glucose Monitoring (CGM) System.
Your patient has previously self-funded their Dexcom ONE CGM System, and has been using since …./…../……….
I can confirm that we have assessed your patient against the initiation and continuation criteria, and can confirm that they meet both sets of criteria, and that ICB funding has been approved. Please can you commence repeat prescriptions for Dexcom ONE as detailed in the letter below.
For this patient, on-going use of the Dexcom ONE CGM system is demonstrably improving diabetes self-management as indicated by:
o Reduction in HbA1c of 0.5%/5mmol/mol or more
o Improvement of Time in Range
o Reduction in episodes of DKA
o Reduction in hypoglycaemia episodes
o Improved hypoglycaemia awareness
o Reduction in admissions to hospital
o Clear benefit to carer support and glucose monitoring for type 1 diabetes patients unable to self-monitor blood glucose due to disability
o Improvement in psychosocial wellbeing as indicated by ……………………………
……………………………………………………………………………………………..
Use of the Dexcom ONE CGM system will only be continued at the discretion of the diabetes specialist team if there is continuing sustained benefit in patient outcomes whilst they are using the device. Your patient will have regular ongoing reviews with the diabetes specialist team and has agreed to these terms and understands that NHS funding may be withdrawn if no on-going benefit is seen. Under these circumstances they would then have the option to continue to self-fund use of
the device. You will be contacted by the diabetes specialist team in the future if NHS prescriptions for Dexcom ONE are to be stopped.
Although quantities required may have reduced, please be aware that your patient will continue to require blood glucose test strips.
a) I would be grateful if you would make the following changes to your patient’s repeat prescription items, at your earliest convenience. This has been discussed with the patient.
1. Dexcom ONE sensors (PIP CODE: 421-4722) - 1 pack of 3 sensors
This should be sufficient for a 30-day supply – please allow up to 6 to 12 repeat prescriptions.
2. Dexcom ONE transmitter (PIP CODE: 421-4730) – 1 pack of 1 transmitter
This should be sufficient for a 90-day supply – please allow up to 4 repeat prescriptions.
We will advise you if/when to discontinue.
b) Please continue all other items as currently prescribed (including blood glucose testing strips).
c) Your patient will be followed up by the specialist team regularly and will be required to share their CGM data via Dexcom Clarity, as advised by their diabetes specialist team, for ongoing support.
Please see our local Dexcom ONE FAQs document for further information.
Thank you for your help.
Yours sincerely
Diabetes Specialist Team